Cleara

3 known investors

Cleara Biotech is a biopharmaceutical R&D company developing peptide-based therapies that selectively eliminate cells with impaired p53 signaling, targeting cancer and chronic diseases. Its lead development candidates, CL04177 and CL04183, aim to induce apoptosis in cancer cells with mutant or impaired p53, with preclinical work in metastatic colon cancer and triple-negative breast cancer.